Evidence map›Paper›PMID 24989021›Full record

ArticleGenome research2014

Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases.

Séverine Remy, Laurent Tesson, Séverine Menoret, Claire Usal, Anne De Cian, Virginie Thepenier, Reynald Thinard, Daniel Baron, Marine Charpentier, Jean-Baptiste Renaud and 6 more

Abstract read
In one paragraph

Article in Genome research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Advances in Immunocompetent Mouse and Rat Models.Cold Spring Harbor perspectives in medicine · 2024
    Review
  3. Article
  4. Article
  5. CD4BMC biology · 2023
    Article
  6. Review
  7. Recent Advances in the Production of Genome-Edited Rats.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. Mutation-Directed Therapeutics for Neurofibromatosis Type I.Molecular therapy. Nucleic acids · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Séverine RemyINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;
Laurent TessonINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;
Séverine MenoretINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;
Claire UsalINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;
Anne De CianINSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, F75005 Paris, France;
Virginie ThepenierINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;
Reynald ThinardINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;
Daniel BaronINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France;
Marine CharpentierINSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, F75005 Paris, France;
Jean-Baptiste RenaudINSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, F75005 Paris, France;
Roland BuelowOpen Monoclonal Technologies, Palo Alto, California 94303, USA;
Gregory J CostSangamo BioSciences, Richmond, California 94804, USA;
Carine GiovannangeliINSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, F75005 Paris, France;
Alexandre FraichardgenOway, Lyon F69007, France.
Jean-Paul ConcordetINSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, F75005 Paris, France;
Ignacio AnegonINSERM UMR 1064-ITUN, CHU de Nantes, Nantes F44093, France; Platform Rat Transgenesis, Nantes F44093, France;

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The generation of genetically modified animals is important for both research and commercial purposes. The rat is an important model organism that until recently lacked efficient genetic engineering tools. Sequence-specific nucleases, such as ZFNs, TALE nucleases, and CRISPR/Cas9 have allowed the creation of rat knockout models. Genetic engineering by homology-directed repair (HDR) is utilized to create animals expressing transgenes in a controlled way and to introduce precise genetic modifications. We applied TALE nucleases and donor DNA microinjection into zygotes to generate HDR-modified rats with large new sequences introduced into three different loci with high efficiency (0.62%-5.13% of microinjected zygotes). Two of these loci (Rosa26 and Hprt1) are known to allow robust and reproducible transgene expression and were targeted for integration of a GFP expression cassette driven by the CAG promoter. GFP-expressing embryos and four Rosa26 GFP rat lines analyzed showed strong and widespread GFP expression in most cells of all analyzed tissues. The third targeted locus was Ighm, where we performed successful exon exchange of rat exon 2 for the human one. At all three loci we observed HDR only when using linear and not circular donor DNA. Mild hypothermic (30°C) culture of zygotes after microinjection increased HDR efficiency for some loci. Our study demonstrates that TALE nuclease and donor DNA microinjection into rat zygotes results in efficient and reproducible targeted donor integration by HDR. This allowed creation of genetically modified rats in a work-, cost-, and time-effective manner.

Indexed as

Gene TargetingGenetic EngineeringAnimalsBase SequenceCells, CulturedDNA Restriction EnzymesFemaleHypoxanthine PhosphoribosyltransferaseMaleMicroinjectionsRats, Sprague-DawleyRats, TransgenicRecombinant ProteinsRecombinational DNA RepairZygoteDNA Restriction EnzymesHypoxanthine PhosphoribosyltransferaseRecombinant Proteins

Identifiers

PMID24989021
PMCPMC4120090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.